retatrutide facts Substack Series 3 of 6: – The Next Frontier in Longevity and Metabolic Health If retatrutide isn't FDA approved

123 Multi agonists In recent years, the development of dual and triple agonists related to GLP-1 has been vigorously pursued

Vallf, D., Kalafateli, A

NAD+ is the primary metabolic add-on for KLOW because collagen and tissue remodeling are energy-intensive: repair cells need NAD+ to produce energy, repair DNA, and keep building new tissue

The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats PMID: 11735244 Growth Horm IGF Res

Dipeptidyl peptidase 4 (DPP-4) inhibitors inhibit DPP-4, which is a ubiquitous enzyme expressed on the surface of most cell types that deactivates GLP-1

Cardiovascular Health: ALCAR's beneficial effects extend to cardiovascular health